InflaRx (IFRX) Operating Expenses (2022 - 2025)
Historic Operating Expenses for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to -$11.7 million.
- InflaRx's Operating Expenses rose 3181.24% to -$11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.0 billion, marking a year-over-year increase of 1980.48%. This contributed to the annual value of -$52.4 million for FY2024, which is 927.59% up from last year.
- Per InflaRx's latest filing, its Operating Expenses stood at -$11.7 million for Q3 2025, which was up 3181.24% from -$13.0 billion recorded in Q2 2025.
- InflaRx's 5-year Operating Expenses high stood at -$11.0 million for Q4 2024, and its period low was -$53456.5 billion during Q4 2022.
- Over the past 4 years, InflaRx's median Operating Expenses value was -$16.7 million (recorded in 2022), while the average stood at -$6681.1 billion.
- Examining YoY changes over the last 5 years, InflaRx's Operating Expenses showed a top increase of 10000.0% in 2023 and a maximum decrease of 21738090226.46% in 2023.
- Over the past 4 years, InflaRx's Operating Expenses (Quarter) stood at -$53456.5 billion in 2022, then skyrocketed by 100.0% to -$11.5 million in 2023, then rose by 3.79% to -$11.0 million in 2024, then fell by 6.37% to -$11.7 million in 2025.
- Its Operating Expenses stands at -$11.7 million for Q3 2025, versus -$13.0 billion for Q2 2025 and -$14.2 million for Q1 2025.